Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?

Cardiology in the young·2026

Same author

How Close Are We? Neuropsychologic Assessment in New-Onset Pediatric Epilepsy.

Pediatric neurology·2025

Same author

Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis.

Neurology·2025

Same author

Neurofibromatosis type 2-related schwannomatosis - An update.

Seminars in pediatric neurology·2024

Same author

Isolated Psychiatric Symptoms in Children With Anti-N-Methyl-d Aspartate Receptor Encephalitis.

Pediatric neurology·2024

Same author

MRI Features and Their Association With Outcomes in Children With Anti-NMDA Receptor Encephalitis.

Neurology(R) neuroimmunology & neuroinflammation·2023

Search research articles

Related Experiment Video

Updated: Jul 20, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Neurofibromatosis type 1 - an update.

Manikum Moodley¹, Karla Robles Lopez¹

¹Pediatric Neuroscience at Dell Children's Medical CenterThe University of Texas at Austin Dell Medical School, USA.

Seminars in Pediatric Neurology

|December 2, 2024

Summary

Neurofibromatosis type 1 (NF1) is a common genetic disorder with varied symptoms like skin changes and tumors. While a cure is unavailable, new treatments target the RAS/MAPK pathway.

Keywords:

Café-au-lait macules Child neurology Lisch nodules NF1 Neurofibromas Neurofibromatosis Optic glioma Pediatric neurology

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Published on: May 17, 2024

Related Experiment Videos

Last Updated: Jul 20, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Published on: May 17, 2024

Area of Science:

Genetics
Dermatology
Oncology

Background:

Neurofibromatosis type 1 (NF1) is a prevalent autosomal dominant genetic condition.
NF1 presents with diverse clinical manifestations, including café-au-lait macules, neurofibromas, and Lisch nodules.
The condition exhibits complete penetrance but significant variability in disease expression.

Purpose of the Study:

To summarize the key features and current understanding of Neurofibromatosis type 1.
To highlight the variability in clinical presentation and disease onset.
To introduce emerging therapeutic strategies for NF1.

Main Methods:

Literature review of Neurofibromatosis type 1.
Analysis of clinical characteristics and genetic inheritance patterns.
Overview of current and developing treatment modalities.

Main Results:

NF1 is characterized by a spectrum of physical findings, with some appearing in early childhood and others later in life.
Café-au-lait macules, bony abnormalities, and optic pathway gliomas are common early signs.
Variable expressivity is a hallmark of NF1, impacting diagnosis and management.

Conclusions:

Neurofibromatosis type 1 is a complex genetic disorder requiring lifelong monitoring.
Management of NF1 involves addressing diverse symptoms and potential complications.
Targeting the RAS/MAPK signaling pathway represents a promising therapeutic avenue for NF1.